151 related articles for article (PubMed ID: 15767744)
21. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
Zheng J; Cui S; Meng J
J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
[TBL] [Abstract][Full Text] [Related]
22. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones.
Cebrian L; Sirvent E; Rodríguez Díaz JC; Ruiz M; Royo G
Int J Antimicrob Agents; 2003 Aug; 22(2):134-9. PubMed ID: 12927953
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
Capilla S; Ruiz J; Goñi P; Castillo J; Rubio MC; Jiménez de Anta MT; Gómez-Lus R; Vila J
J Antimicrob Chemother; 2004 Jun; 53(6):1068-71. PubMed ID: 15117921
[TBL] [Abstract][Full Text] [Related]
25. Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp.
Escribano I; Rodríguez JC; Pertegás V; Cebrian L; Royo G
J Infect Chemother; 2006 Aug; 12(4):177-80. PubMed ID: 16944254
[TBL] [Abstract][Full Text] [Related]
26. Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G).
Preisler A; Mraheil MA; Heisig P
J Antimicrob Chemother; 2006 Mar; 57(3):430-6. PubMed ID: 16431864
[TBL] [Abstract][Full Text] [Related]
27. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
28. Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression.
Randall LP; Eaves DJ; Cooles SW; Ricci V; Buckley A; Woodward MJ; Piddock LJ
J Antimicrob Chemother; 2005 Aug; 56(2):297-306. PubMed ID: 15956100
[TBL] [Abstract][Full Text] [Related]
29. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
[TBL] [Abstract][Full Text] [Related]
30. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
[TBL] [Abstract][Full Text] [Related]
31. In vivo selection of aac(6')-Ib-cr and mutations in the gyrA gene in a clinical qnrS1-positive Salmonella enterica serovar Typhimurium DT104B strain recovered after fluoroquinolone treatment.
de Toro M; Rojo-Bezares B; Vinué L; Undabeitia E; Torres C; Sáenz Y
J Antimicrob Chemother; 2010 Sep; 65(9):1945-9. PubMed ID: 20639314
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the Fluoroquinolone Antibiotic Resistance Mechanism of Salmonella enterica Isolates.
Kim SY; Lee SK; Park MS; Na HT
J Microbiol Biotechnol; 2016 Sep; 26(9):1605-12. PubMed ID: 27116992
[TBL] [Abstract][Full Text] [Related]
33. Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the midwestern region of the Republic of Ireland due to mutations in the gyrA gene.
Ryan MP; Dillon C; Adley CC
J Clin Microbiol; 2011 May; 49(5):2077-9. PubMed ID: 21389151
[No Abstract] [Full Text] [Related]
34. Detection of decreased susceptibility to fluoroquinolones in Salmonella spp. by five different methods including real-time polymerase chain reaction (PCR).
Aznar E; Alarcon T; Buendía B; García-Peñuela E; López-Brea M
Int J Antimicrob Agents; 2007 Jul; 30(1):67-71. PubMed ID: 17400429
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of strains of fluoroquinolone-resistant Salmonella enterica serovar Schwarzengrund carrying multidrug resistance isolated from imported foods.
Akiyama T; Khan AA
J Antimicrob Chemother; 2012 Jan; 67(1):101-10. PubMed ID: 22010209
[TBL] [Abstract][Full Text] [Related]
36. Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
Delsol AA; Woodward MJ; Roe JM
J Antimicrob Chemother; 2004 Feb; 53(2):396-8. PubMed ID: 14711838
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones.
Castanheira M; Deshpande LM; Jones RN; Farrell DJ
Diagn Microbiol Infect Dis; 2012 Mar; 72(3):263-6. PubMed ID: 22321998
[TBL] [Abstract][Full Text] [Related]
38. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
Pasquali F; Manfreda G
Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
[TBL] [Abstract][Full Text] [Related]
39. Efflux pump activity in fluoroquinolone and tetracycline resistant Salmonella and E. coli implicated in reduced susceptibility to household antimicrobial cleaning agents.
Thorrold CA; Letsoalo ME; Dusé AG; Marais E
Int J Food Microbiol; 2007 Feb; 113(3):315-20. PubMed ID: 17126442
[TBL] [Abstract][Full Text] [Related]
40. [Drug resistance and related genes of chickenborne Salmonella to quinolone and fluoroquinolones].
Hao H; Yang B; Shi J; Xi M; Wang X; Cui Y; Meng J
Wei Sheng Wu Xue Bao; 2011 Oct; 51(10):1413-20. PubMed ID: 22233064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
